Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.
(1994) Annals of Surgery — Vol. 220, n° 3, p. 297-308; discussion 308-9 (1994)
Files
Todo-1994-Single-centerexperiencewithprimary.pdf
Restricted Access - Adobe PDF
- 1.78 MB
Details
- Authors
- Abstract
- The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined.
- Affiliations
University of Pittsburgh, School of Medicine,, Pennsylvania, USA Pittsburgh Transplant Institute
Citations
Todo, S., Fung, J. J., Starzl, T. E., Tzakis, A., Doyle, H., Abu-Elmagd, K., Jain, A., Selby, R., Bronsther, O., Marsh, W., Ramos, H., Reyes, J., Gayowski, T., Casavilla, A., Dodson, F., Furukawa, H., Marino, I., Pinna, A., Nour, B., et al. (1994). Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Annals of Surgery, 220(3), 297-308; discussion 308-9. https://hdl.handle.net/2078.5/72166 (Original work published 1994)